• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Charles River Laboratories International Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    5/10/21 6:37:00 PM ET
    $TDY
    $SPGI
    $CRL
    $NSA
    Industrial Machinery/Components
    Industrials
    Finance: Consumer Services
    Finance
    Get the next $TDY alert in real time by email

    NEW YORK, May 10, 2021 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600:

    • S&P MidCap 400 constituent Charles River Laboratories International (NYSE:CRL) will replace FLIR Systems Inc. (NASD:FLIR) in the S&P 500, S&P SmallCap 600 constituent National Storage Affiliates Trust (NYSE:NSA) will replace Charles River Laboratories International in the S&P MidCap 400, and Ellington Financial Inc. (NYSE:EFC) will replace National Storage Affiliates Trust in the S&P SmallCap 600 effective prior to the opening of trading on Friday, May 14. S&P 500 constituent Teledyne Technologies Inc. (NYSE:TDY) is acquiring FLIR Systems in a deal to be completed soon pending final closing conditions.
    • Aspen Technology Inc. (NASD:AZPN) will replace Avanos Medical Inc. (NYSE:AVNS) in the S&P MidCap 400, and Avanos Medical will replace Aegion Corp. (NASD:AEGN) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, May 17. New Mountain Capital LLC is acquiring Aegion in a deal expected to be completed soon pending final closing conditions.

    Following is a summary of the changes that will take place prior to the open of trading on the effective date:

    Effective Date

    Index Name      

    Action

    Company Name

    Ticker

    GICS Sector

    May 14, 2021

    S&P 500

    Addition

    Charles River Laboratories Intl

    CRL

    Health Care



    S&P 500

    Deletion

    FLIR Systems

    FLIR

    Information Technology



    S&P MidCap 400

    Addition

    National Storage Affiliates Trust

    NSA

    Real Estate



    S&P MidCap 400

    Deletion

    Charles River Laboratories Intl

    CRL

    Health Care



    S&P SmallCap 600

    Addition

    Ellington Financial

    EFC

    Financials



    S&P SmallCap 600

    Deletion

    National Storage Affiliates Trust

    NSA

    Real Estate

    May 17, 2021

    S&P MidCap 400

    Addition

    Aspen Technology

    AZPN

    Information Technology



    S&P MidCap 400

    Deletion

    Avanos Medical

    AVNS

    Health Care



    S&P SmallCap 600

    Addition

    Avanos Medical

    AVNS

    Health Care



    S&P SmallCap 600

    Deletion

    Aegion

    AEGN

    Industrials

    For more information about S&P Dow Jones Indices, please visit www.spdji.com

    ABOUT S&P DOW JONES INDICES

    S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.

    S&P Dow Jones Indices is a division of S&P Global (NYSE:SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spdji.com.

    FOR MORE INFORMATION:

    S&P Dow Jones Indices

    [email protected]

    Media Inquiries

    [email protected]

    Cision View original content:http://www.prnewswire.com/news-releases/charles-river-laboratories-international-set-to-join-sp-500-others-to-join-sp-midcap-400-and-sp-smallcap-600-301287994.html

    SOURCE S&P Dow Jones Indices

    Get the next $TDY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TDY
    $SPGI
    $CRL
    $NSA

    CompanyDatePrice TargetRatingAnalyst
    Charles River Laboratories International Inc.
    $CRL
    5/8/2025$170.00In-line → Outperform
    Evercore ISI
    S&P Global Inc.
    $SPGI
    4/10/2025$600.00Buy
    BofA Securities
    Charles River Laboratories International Inc.
    $CRL
    3/21/2025$190.00 → $170.00Buy → Neutral
    Goldman
    S&P Global Inc.
    $SPGI
    3/12/2025$599.00Outperform
    Mizuho
    Charles River Laboratories International Inc.
    $CRL
    3/4/2025$155.00 → $175.00Sell → Neutral
    Citigroup
    Charles River Laboratories International Inc.
    $CRL
    3/3/2025$188.00Sell → Neutral
    Redburn Atlantic
    Aspen Technology Inc.
    $AZPN
    2/10/2025$265.00 → $315.00Hold → Buy
    Loop Capital
    Aspen Technology Inc.
    $AZPN
    2/5/2025$260.00 → $265.00Buy → Hold
    Loop Capital
    More analyst ratings

    $TDY
    $SPGI
    $CRL
    $NSA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • EVP, Chief Client Officer Moore Sally sold $255,148 worth of shares (500 units at $510.43), decreasing direct ownership by 9% to 5,131 units (SEC Form 4)

      4 - S&P Global Inc. (0000064040) (Issuer)

      5/7/25 5:33:08 PM ET
      $SPGI
      Finance: Consumer Services
      Finance
    • EVP, Chief Legal Officer Kemps Steven J sold $1,017,640 worth of shares (2,000 units at $508.82), decreasing direct ownership by 22% to 7,249 units (SEC Form 4)

      4 - S&P Global Inc. (0000064040) (Issuer)

      5/7/25 5:32:23 PM ET
      $SPGI
      Finance: Consumer Services
      Finance
    • Corporate Executive VP & CFO Pease Flavia covered exercise/tax liability with 889 shares, decreasing direct ownership by 8% to 10,661 units (SEC Form 4)

      4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)

      5/5/25 5:44:33 PM ET
      $CRL
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care

    $TDY
    $SPGI
    $CRL
    $NSA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Changing Restrictions on Russian Gas to Europe Would Disproportionately Impact US LNG Exports, New S&P Global Commodity Insights Study Finds

      Future course of sanctions and flow of Russian gas to Europe could impact up to $120 billion of investment and 29 MMtpa for future U.S. LNG projects WASHINGTON, May 8, 2025 /PRNewswire/ -- The United States, which currently supplies half of Europe's liquefied natural gas (LNG) imports and roughly 15% of the continent's total gas supply, would be disproportionately impacted if current restrictions on Russian gas and LNG were to change, a new S&P Global Commodity Insights study finds. The report, U.S. LNG Exports at Risk: Potential Unwinding of Sanctions on Russian Natural Gas found that, under an "Opening the Taps" scenario where U.S. sanctions on Russian natural gas pipeline and LNG exports

      5/8/25 11:41:00 AM ET
      $SPGI
      Finance: Consumer Services
      Finance
    • Ellington Financial Inc. Reports First Quarter 2025 Results

      Ellington Financial Inc. (NYSE:EFC) ("we") today reported financial results for the quarter ended March 31, 2025. Highlights Net income attributable to common stockholders of $31.6 million, or $0.35 per common share.1 $57.1 million, or $0.63 per common share, from the investment portfolio. $52.9 million, or $0.58 per common share, from the credit strategy. $4.2 million, or $0.05 per common share, from the Agency strategy. $(1.0) million, or $(0.01) per common share, from Longbridge. Adjusted Distributable Earnings2 of $35.5 million, or $0.39 per common share. Book value per common share as of March 31, 2025 of $13.44, including the effects of dividends of $0.39 per common

      5/7/25 4:59:00 PM ET
      $EFC
      Real Estate
      Finance
    • Ellington Financial Declares Monthly Common Dividend

      Ellington Financial Inc. (NYSE:EFC) ("we") today announced that its Board of Directors has declared a monthly dividend of $0.13 per share of common stock, payable on June 30, 2025 to stockholders of record as of May 30, 2025. Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve numerous risks and uncertainties. Our actual results may differ from its beliefs, expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of f

      5/7/25 4:15:00 PM ET
      $EFC
      Real Estate
      Finance

    $TDY
    $SPGI
    $CRL
    $NSA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Avanos Medical Inc.

      SC 13G - AVANOS MEDICAL, INC. (0001606498) (Subject)

      11/14/24 1:28:34 PM ET
      $AVNS
      Industrial Specialties
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Teledyne Technologies Incorporated

      SC 13G/A - TELEDYNE TECHNOLOGIES INC (0001094285) (Subject)

      11/14/24 1:28:28 PM ET
      $TDY
      Industrial Machinery/Components
      Industrials
    • Amendment: SEC Form SC 13G/A filed by Teledyne Technologies Incorporated

      SC 13G/A - TELEDYNE TECHNOLOGIES INC (0001094285) (Subject)

      11/14/24 1:22:34 PM ET
      $TDY
      Industrial Machinery/Components
      Industrials

    $TDY
    $SPGI
    $CRL
    $NSA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Charles River upgraded by Evercore ISI with a new price target

      Evercore ISI upgraded Charles River from In-line to Outperform and set a new price target of $170.00

      5/8/25 8:24:10 AM ET
      $CRL
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • BofA Securities resumed coverage on S&P Global with a new price target

      BofA Securities resumed coverage of S&P Global with a rating of Buy and set a new price target of $600.00

      4/10/25 8:19:38 AM ET
      $SPGI
      Finance: Consumer Services
      Finance
    • Charles River downgraded by Goldman with a new price target

      Goldman downgraded Charles River from Buy to Neutral and set a new price target of $170.00 from $190.00 previously

      3/21/25 8:03:14 AM ET
      $CRL
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care

    $TDY
    $SPGI
    $CRL
    $NSA
    Leadership Updates

    Live Leadership Updates

    See more
    • Charles River Laboratories Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value

      – Board Approves Appointment of Four New Directors – – Strategic Planning and Capital Allocation Committee of the Board to Conduct Comprehensive Strategic Review of the Company's Business – – Enters into Cooperation Agreement with Elliott Investment Management – Charles River Laboratories International, Inc. (NYSE:CRL) today announced that four new directors will join its Board of Directors and that four long-time members of the Board will not seek re-election at the 2025 Annual Meeting of Shareholders. The Company also announced changes to its Board committees and a strategic review of the Company's business focused on enhancing long-term value for shareholders. Charles River's Board o

      5/7/25 7:00:00 AM ET
      $CRL
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • Okta Set to Join S&P MidCap 400

      NEW YORK, April 28, 2025 /PRNewswire/ -- Okta Inc. (NASD: OKTA) will replace Berry Global Group Inc. (NYSE:BERY) in the S&P MidCap 400 effective prior to the opening of trading on Thursday, May 1. S&P 500 constituent Amcor plc (NYSE:AMCR) is acquiring Berry Global Group in a deal expected to close soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector May 1, 2025 S&P MidCap 400 Addition Okta OKTA Information Technology May 1, 2025 S&P MidCap 400 Deletion Berry Global Group BERY Materials For more information about S&P Dow Jon

      4/28/25 6:07:00 PM ET
      $AMCR
      $BERY
      $OKTA
      $SPGI
      Miscellaneous manufacturing industries
      Consumer Discretionary
      Plastic Products
      Industrials
    • Teledyne Appoints George Bobb as Chief Executive Officer

      Teledyne Technologies Incorporated (NYSE:TDY) ("Teledyne") announced today that Teledyne's Board of Directors named George C. Bobb III as Teledyne's President and Chief Executive Officer, effective immediately. Simultaneously, Edwin Roks has retired as Teledyne's Chief Executive Officer, but will continue as a special advisor to Robert Mehrabian, Executive Chairman, through August 31, 2025. "George has worked with me at Teledyne for 17 years and has excelled at every assignment given to him, including most recently as Teledyne's President and Chief Operating Officer," said Robert Mehrabian, Executive Chairman. "Together, George and I will continue the development and execution of Teledyne'

      4/28/25 4:05:00 PM ET
      $TDY
      Industrial Machinery/Components
      Industrials

    $TDY
    $SPGI
    $CRL
    $NSA
    Financials

    Live finance-specific insights

    See more
    • Ellington Financial Inc. Reports First Quarter 2025 Results

      Ellington Financial Inc. (NYSE:EFC) ("we") today reported financial results for the quarter ended March 31, 2025. Highlights Net income attributable to common stockholders of $31.6 million, or $0.35 per common share.1 $57.1 million, or $0.63 per common share, from the investment portfolio. $52.9 million, or $0.58 per common share, from the credit strategy. $4.2 million, or $0.05 per common share, from the Agency strategy. $(1.0) million, or $(0.01) per common share, from Longbridge. Adjusted Distributable Earnings2 of $35.5 million, or $0.39 per common share. Book value per common share as of March 31, 2025 of $13.44, including the effects of dividends of $0.39 per common

      5/7/25 4:59:00 PM ET
      $EFC
      Real Estate
      Finance
    • Ellington Financial Declares Monthly Common Dividend

      Ellington Financial Inc. (NYSE:EFC) ("we") today announced that its Board of Directors has declared a monthly dividend of $0.13 per share of common stock, payable on June 30, 2025 to stockholders of record as of May 30, 2025. Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve numerous risks and uncertainties. Our actual results may differ from its beliefs, expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of f

      5/7/25 4:15:00 PM ET
      $EFC
      Real Estate
      Finance
    • Charles River Laboratories Announces First-Quarter 2025 Results

      – First-Quarter Revenue of $984.2 Million – – First-Quarter GAAP Earnings per Share of $0.50 and Non-GAAP Earnings per Share of $2.34 – – Increases 2025 Guidance – – Repurchased $350 Million of Common Stock in First Quarter of 2025 – Charles River Laboratories International, Inc. (NYSE:CRL) today reported its results for the first quarter of 2025. For the quarter, revenue was $984.2 million, a decrease of 2.7% from $1,011.6 million in the first quarter of 2024. The impact of foreign currency translation reduced reported revenue by 0.9%. Excluding this impact, revenue decreased 1.8% on an organic basis driven by declines in all three business segments. In the first quarter of 2025, the

      5/7/25 7:01:00 AM ET
      $CRL
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care

    $TDY
    $SPGI
    $CRL
    $NSA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Schall Michael J bought $154,160 worth of Common shares of beneficial interest (4,000 units at $38.54), increasing direct ownership by 200% to 6,000 units (SEC Form 4)

      4 - National Storage Affiliates Trust (0001618563) (Issuer)

      3/10/25 4:05:29 PM ET
      $NSA
      Real Estate Investment Trusts
      Real Estate
    • Chairman, President and CEO Foster James C bought $1,002,436 worth of shares (6,075 units at $165.01), increasing direct ownership by 3% to 183,639 units (SEC Form 4)

      4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)

      2/21/25 4:41:25 PM ET
      $CRL
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • Corporate Executive VP & COO Girshick Birgit bought $249,250 worth of shares (1,514 units at $164.63), increasing direct ownership by 3% to 55,058 units (SEC Form 4)

      4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)

      2/21/25 4:38:37 PM ET
      $CRL
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care

    $TDY
    $SPGI
    $CRL
    $NSA
    SEC Filings

    See more
    • Ellington Financial Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Ellington Financial Inc. (0001411342) (Filer)

      5/7/25 5:09:26 PM ET
      $EFC
      Real Estate
      Finance
    • Ellington Financial Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - Ellington Financial Inc. (0001411342) (Filer)

      5/7/25 4:26:22 PM ET
      $EFC
      Real Estate
      Finance
    • SEC Form 10-Q filed by Charles River Laboratories International Inc.

      10-Q - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Filer)

      5/7/25 9:09:41 AM ET
      $CRL
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care